Filtros de búsqueda

Lista de obras de Karen Kelly

50 Years of progress in the systemic therapy of non-small cell lung cancer

artículo científico publicado en 2014

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients.

artículo científico publicado en 2017

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2016

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

artículo científico publicado en 2013

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533

artículo científico publicado en 2015

A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors

artículo científico publicado en 2004

A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer ⬇️

artículo científico publicado el 1 de febrero de 1998

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

artículo científico publicado en 2018

A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer

artículo científico publicado en 2006

A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity

article

A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials

artículo científico publicado en 2006

A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer

artículo científico publicado en 2009

ACCO: ASCO Core Curriculum Outline

scientific article published on 22 February 2005

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study

scientific article published on 06 August 2018

Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications

artículo científico publicado en 2013

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

artículo científico publicado en 2015

Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity

artículo científico publicado en 2012

Antigens in lung cancer: clinical radio-immunolocalization in lung cancer

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

artículo científico publicado en 2017

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

artículo científico publicado en 2017

Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor.

artículo científico publicado en 2008

Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy

artículo científico publicado en 2006

Challenges in defining and identifying patients with non-small cell lung cancer and poor performance status

artículo científico publicado en 2004

Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses

artículo científico publicado en 2013

Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer.

artículo científico publicado en 2015

Clinical prognostic model for older patients with advanced non-small cell lung cancer

artículo científico publicado en 2019

Comparison of Platinum-Based Chemotherapy in Patients Older and Younger than 70 Years: An Analysis of Southwest Oncology Group Trials 9308 and 9509 ⬇️

artículo científico publicado el 1 de enero de 2011

Current treatment paradigms for locally advanced non-small cell lung cancer

artículo científico publicado en 2007

Detection of K-rasOncogene Mutations by Polymerase Chain Reaction-Based Ligase Chain Reaction

scientific article published on 01 August 1996

Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue

artículo científico publicado en 2015

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials

artículo científico publicado en 2008

Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial

artículo científico publicado en 2007

EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome

article

Effects of imputation on correlation: implications for analysis of mass spectrometry data from multiple biological matrices

artículo científico publicado en 2016

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

artículo científico publicado en 2019

Efficacy and immune-related adverse event associations in avelumab-treated patients

scientific article published on 01 November 2020

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program

artículo científico publicado en 2006

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

artículo científico publicado en 2006

Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer

artículo científico publicado en 2016

Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer.

artículo científico publicado en 2018

First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors

article

First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance

artículo científico publicado en 2018

HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum

artículo científico publicado en 2005

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

artículo científico publicado en 2015

In Reply

In Reply

In Reply

Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis

artículo científico publicado en 2017

Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?

artículo científico publicado en 1998

Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma

artículo científico publicado en 2015

Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules

scientific article published on 01 December 2019

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer

artículo científico publicado en 2015

Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer

artículo científico publicado en 2005

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC

artículo científico publicado en 2018

Multivariate two-part statistics for analysis of correlated mass spectrometry data from multiple biological specimens.

artículo científico publicado en 2016

N-Glycan profiling of dried blood spots

artículo científico publicado en 2011

Novel approaches for the treatment of small cell lung cancer

artículo científico publicado en 2004

Oral iloprost improves endobronchial dysplasia in former smokers

artículo científico publicado en 2011

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.

artículo científico publicado en 2018

Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial

artículo científico publicado en 2008

Peptide amidating activity in human bronchoalveolar lavage fluid

artículo científico publicado en 1996

Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure

artículo científico publicado en 2018

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

artículo científico publicado en 2008

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors

artículo científico publicado en 2015

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

artículo científico publicado en 2022

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib

artículo científico publicado en 2015

Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914

article published in 2006

Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342

artículo científico publicado en 2010

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

artículo científico publicado en 2007

Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer

artículo científico publicado en 2004

Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536

artículo científico publicado en 2013

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

artículo científico publicado en 2008

Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.

artículo científico publicado en 2017

Potential role of platelet-derived growth factor receptor inhibition using imatinib in combination with docetaxel in the treatment of recurrent non-small cell lung cancer

artículo científico publicado en 2011

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer

artículo científico publicado en 2016

Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer

artículo científico publicado en 2002

Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis

artículo científico publicado en 2014

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer

artículo científico publicado en 1995

Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage

scientific article published in 1993

Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial

artículo científico publicado en 2002

Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

artículo científico publicado en 2006

Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy

artículo científico publicado en 2012

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.

artículo científico publicado en 2017

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials

artículo científico publicado en 2015

Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer

artículo científico publicado en 2015

Response to H. Nabi et al.

artículo científico publicado en 2018

Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer: A Review

artículo científico publicado en 2019

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

scientific article published on 31 May 2019

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

scientific article published on 11 June 2019

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

artículo científico publicado en 2018

Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.

artículo científico publicado en 2016

Single-Institution Experience with Pemetrexedand Bevacizumab as Salvage Therapy in AdvancedNon–Small-Cell Lung Cancer

artículo científico publicado en 2007

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer

artículo científico publicado en 2014

Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site

artículo científico publicado en 2018

Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium

artículo científico publicado en 2009

Survival benefits associated with surgery for advanced non-small cell lung cancer

artículo científico publicado en 2018

The Ever-Increasing Number of Trial Eligibility Criteria: Time to Bend the Curve.

artículo científico publicado en 2017

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.

artículo científico publicado en 2016

The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-small Cell Lung Cancer

artículo científico

The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group

scientific article published on 01 December 1994

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2007

The inherited nature of lung cancer: a pilot study

artículo científico publicado en 2000

Therapeutic Strategies for Combined-Modality Therapy of Locally Advanced-Stage Non–Small-Cell Lung Cancer: Rationale for Consolidation Docetaxel Therapy

Tobacco policy recommendations of the International Association for the Study of Lung Cancer (IASLC): a 10 point program ⬇️

artículo científico publicado el 1 de mayo de 1995

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer

article

Treatment of Locally Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2017

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

artículo científico publicado en 2000

Treatment of thymoma: a comparative study between Thailand and the United States and a review of the literature

artículo científico publicado en 2004

Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual...

artículo científico publicado en 2014

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda